Lipid modification and coronary heart disease in type 2 diabetes: different from the general population?
作者信息
Feher M D, Elkeles R S
出版信息
Heart. 1999 Jan;81(1):10-1. doi: 10.1136/hrt.81.1.10.
Abstract
摘要
相似文献
1
Lipid modification and coronary heart disease in type 2 diabetes: different from the general population?2型糖尿病中的脂质修饰与冠心病：与普通人群有别？
Heart. 1999 Jan;81(1):10-1. doi: 10.1136/hrt.81.1.10.
2
Therapy and clinical trials: fibrate therapy in type 2 diabetes - where are we now?治疗与临床试验：2型糖尿病中的贝特类药物治疗——我们目前的进展如何？
Curr Opin Lipidol. 2010 Dec;21(6):554-5. doi: 10.1097/MOL.0b013e3283404ff1.
3
[Diabetes mellitus and coronary artery disease. Update on diagnosis and drug therapy].[糖尿病与冠状动脉疾病。诊断与药物治疗的最新进展]
Dtsch Med Wochenschr. 2007 May 11;132(19):1034-8. doi: 10.1055/s-2007-979377.
4
Diabetes and lipids - a conundrum.糖尿病与血脂——一个难题。
Diabet Med. 2001 Mar;18(3):250. doi: 10.1046/j.1464-5491.2001.00436.x.
5
Combination lipid therapy in type 2 diabetes.2型糖尿病的联合降脂治疗。
N Engl J Med. 2010 Aug 12;363(7):692-4; author reply 694-5. doi: 10.1056/NEJMc1006407.
6
Managing lipid disorders: further evaluation of the VA-HIT.
Curr Diab Rep. 2003 Jun;3(3):245-7. doi: 10.1007/s11892-003-0071-4.
7
High density lipoproteins, diabetes and diabetic macrovascular disease.高密度脂蛋白、糖尿病与糖尿病大血管病变
Diabet Med. 1985 Sep;2(5):348-51. doi: 10.1111/j.1464-5491.1985.tb00648.x.
8
Lipid disorders in NIDDM: implications for treatment.
J Intern Med. 1998 Nov;244(5):361-70. doi: 10.1046/j.1365-2796.1998.00397.x.
9
Importance of high-density lipoprotein cholesterol and triglyceride levels in coronary heart disease.高密度脂蛋白胆固醇和甘油三酯水平在冠心病中的重要性。
Am J Cardiol. 2003 Mar 1;91(5):575-80. doi: 10.1016/s0002-9149(02)03309-x.
10
[Diabetic dyslipoproteinemia: physiopathological bases and treatment prospects].[糖尿病性血脂蛋白异常：生理病理基础与治疗前景]
Fortschr Med Orig. 2001;119(1):37-40.
引用本文的文献
1
Cytoprotective Effects and Mechanisms of Δ-17 Fatty Acid Desaturase in Injured Human Umbilical Vein Endothelial Cells (HUVECs).Δ-17脂肪酸去饱和酶对人脐静脉内皮细胞（HUVECs）损伤的细胞保护作用及机制
Med Sci Monit. 2017 Apr 4;23:1627-1635. doi: 10.12659/msm.903654.
2
Cardiovascular risk stratification and management in pre-diabetes.糖尿病前期的心血管风险分层与管理
Curr Diab Rep. 2014 Jun;14(6):493. doi: 10.1007/s11892-014-0493-1.
3
Prediction of cardiovascular risk. Program is not suitable for diabetic patients.心血管风险预测。该程序不适用于糖尿病患者。
BMJ. 1999 May 22;318(7195):1418; author reply 1419.
Zotero 插件